JP2024543259A5 - - Google Patents
Info
- Publication number
- JP2024543259A5 JP2024543259A5 JP2024531268A JP2024531268A JP2024543259A5 JP 2024543259 A5 JP2024543259 A5 JP 2024543259A5 JP 2024531268 A JP2024531268 A JP 2024531268A JP 2024531268 A JP2024531268 A JP 2024531268A JP 2024543259 A5 JP2024543259 A5 JP 2024543259A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- naphthamide
- carbamimidoyl
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903789A AU2021903789A0 (en) | 2021-11-24 | Methods of treating sars-cov-2 infection | |
| AU2021903789 | 2021-11-24 | ||
| PCT/AU2022/051405 WO2023092180A1 (en) | 2021-11-24 | 2022-11-24 | Methods of treating sars-cov-2 infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543259A JP2024543259A (ja) | 2024-11-20 |
| JP2024543259A5 true JP2024543259A5 (cg-RX-API-DMAC7.html) | 2025-11-25 |
Family
ID=86538440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531268A Pending JP2024543259A (ja) | 2021-11-24 | 2022-11-24 | SARS-CoV-2感染を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250009713A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4436576A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024543259A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240110039A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118574614A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022399231A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3238183A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023092180A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115260100B (zh) * | 2022-08-08 | 2023-12-12 | 赛诺瑞生物医药技术(无锡)有限公司 | 一种用于制备冠状病毒治疗药物的取代酰基胍类化合物和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8669280B2 (en) * | 2005-06-24 | 2014-03-11 | Biotron Limited | Antiviral compounds and methods |
| ES2614269T3 (es) * | 2007-08-03 | 2017-05-30 | Biotron Limited | Procedimientos y composiciones antivíricas frente a la hepatitis C |
| BR112019016316A2 (pt) * | 2017-02-08 | 2020-03-31 | Biotron Limited | Métodos para o tratamento da influenza |
| MX2022006274A (es) * | 2019-11-26 | 2022-10-13 | Biotron Ltd | Metodos de tratamiento de la infeccion por vih-1. |
| KR20220132608A (ko) * | 2020-01-27 | 2022-09-30 | 길리애드 사이언시즈, 인코포레이티드 | SARS CoV-2 감염증을 치료하기 위한 방법 |
| JP7482250B2 (ja) * | 2020-04-06 | 2024-05-13 | ギリアード サイエンシーズ, インコーポレイテッド | 1’-シアノ置換カルバヌクレオシド類似体の吸入製剤 |
-
2022
- 2022-11-24 AU AU2022399231A patent/AU2022399231A1/en active Pending
- 2022-11-24 CN CN202280089709.6A patent/CN118574614A/zh active Pending
- 2022-11-24 JP JP2024531268A patent/JP2024543259A/ja active Pending
- 2022-11-24 WO PCT/AU2022/051405 patent/WO2023092180A1/en not_active Ceased
- 2022-11-24 EP EP22896871.5A patent/EP4436576A4/en active Pending
- 2022-11-24 CA CA3238183A patent/CA3238183A1/en active Pending
- 2022-11-24 KR KR1020247020169A patent/KR20240110039A/ko active Pending
- 2022-11-24 US US18/712,518 patent/US20250009713A1/en active Pending